FARALLON CAPITAL MANAGEMENT LLC 13D and 13G filings for Enanta Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 1:08 pm Sale | 2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | FARALLON CAPITAL MANAGEMENT LLC | 1,573,829 7.700% | -201,171 (-11.33%) | Filing |
| 2021-02-12 6:42 pm Purchase | 2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 8.800% | 25,000 (+1.43%) | Filing |
| 2020-02-14 06:19 am Purchase | 2019-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA | FARALLON CAPITAL MANAGEMENT LLC | 1,750,000 8.800% | 575,000 (+48.94%) | Filing |